아센디스 파마(ASND)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $237.23 (-0.76%), 시가총액 $15.21B, PER (주가수익비율) 28.05, 52주 최저~최고 $157.27 ~ $249.84.
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
아센디스 파마의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
아센디스 파마의 현재 주가는 $237.23 (-0.76%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
아센디스 파마의 시가총액은 약 $15.21B입니다. PER은 28.05입니다.
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company